

Author: Goodin D.S.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 655-670
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Therapeutic developments in amyotrophic lateral sclerosis
By Lai E.C.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. :




Novel therapeutic agents for multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. :

